Feeding and neuroendocrine responses after recurrent insulin-induced hypoglycemia

Physiology and Behavior

Volumn 87, Issue 4, 2006, Pages 700-706

  Sanders, Nicole M ^a,b   Figlewicz, Dianne P ^a,b   Taborsky Jr , G J ^a,b   Wilkinson, Charles W ^a,b   Daumen, Wendi ^c   Levin, Barry E ^d  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Food intake; Glucoprivation; Hypoglycemia; Hypoglycemia counterregulation; Hypoglycemia associated autonomic failure

Indexed keywords

ADRENALIN; GLUCAGON; GLUCOSE; INSULIN; NORADRENALIN;

ADAPTIVE BEHAVIOR; ADRENALIN RELEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEEDING BEHAVIOR; FOOD INTAKE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HORMONE DETERMINATION; HORMONE SENSITIVITY; HYPERPHAGIA; HYPOGLYCEMIA; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; RECURRENT DISEASE;

EID: 33645931661     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2006.01.007     Document Type: Article

References (53)

1. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes 46 (1997) 271-286
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
3. UK Prospective Diabetes Study. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352 (1998) 837-853
4. Dagogo-Jack S.E., Craft S., and Cryer P.E. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 91 (1993) 819-828
5. Schultes B., Oltmanns K.M., Kern W., Fehm H.L., Born J., and Peters A. Modulation of hunger by plasma glucose and metformin. J Endo Metab 88 (2003) 1133-1141
6. Smith G.P., and Epstein A.N. Increased feeding in response to decreased glucose utilization in the rat and monkey. Am J Physiol 217 (1969) 1083-1087
7. Miselis R.R., and Epstein A.N. Feeding induced by intracerebroventricular 2-deoxy-d-glucose in the rat. Am J Physiol 229 (1975) 1438-1447
8. Dewan S., Gillett A., Mugarza J.A., Dovey T.M., Halford J.C.G., and Wilding J.P.H. Effects of insulin-induced hypoglycaemia on energy intake and food choice at a subsequent test meal. Diabetes Metab Res Rev 20 (2004) 405-410
9. MacKay E.M., Callaway J.W., and Barnes R.H. Hyperalimentation in normal animals produced by protamine insulin. J Nutr 20 (1940) 59-66
10. Grossman M.I., and Stein I.F. Vagotomy and the hunger-producing activity of insulin in man. J Appl Physiol 1 (1948) 263-269
11. Thompson D.A., and Campbell R.G. Hunger in humans induced by 2-deoxy-d-glucose: glucoprivic control of taste preference and food intake. Science 198 (1977) 1065-1068
12. Cryer P.E. Hierarchy of physiological responses to hypoglycemia: relevance to clinical hypoglycemia in type I (insulin dependent) diabetes mellitus. Horm Metab Res 29 (1997) 92-106
13. Evans S., Wilkinson C., Bentson K., Gronbeck P., Zavosh A., and Figlewicz D. PVN activation is suppressed by repeated hypoglycemia but not antecedent corticosterone in the rat. Am J Physiol 281 (2001) R1426-R1436
14. Evans M.I., Halter J.B., and Porte D. Comparison of double-and single-isotope enzymatic derivative methods for measuring catecholamines in human plasma. Clin Chem 24 (1978) 567-570
15. Van Dijk G., Donahey J.C., Thiele T.E., Scheurink A.J., Steffens A., Wilkinson C.W., et al. Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes 46 (1997) 1911-1914
16. Sandoval D.A., Ping L., Neill R.A., Morrey S., and Davis S.N. Cortisol acts through central mechanisms to blunt counterregulatory responses to hypoglycemia in conscious rats. Diabetes 52 (2003) 2198-2204
17. Sandoval D.A., Ping L., Neill R.A., Gong B., Walsh K., and Davis S.N. Brain region-dependent effects of dexamethasone on counterregulatory responses to hypoglycemia in conscious rats. Am J Physiol, Regul Integr Comp Physiol 288 (2005) R413-R419
18. Flanagan D.E., Keshavarz T., Evans M.L., Flanagan S., Fan X., Jacob R.J., et al. Role of corticotrophin-releasing hormone in the impairment of counterregulatory responses to hypoglycemia. Diabetes 52 (2003) 605-613
19. de Vries M.G., Lawson M.A., and Beverly J.L. Dissociation of hypothalamic noradrenergic activity and sympathoadrenal responses to recurrent hypoglycemia. Am J Physiol 286 (2004) R910-R915
20. Shum K., Inouye K., Chan O., Mathoo J., Bilinski D., Matthews S.G., et al. Effects of antecedent hypoglycemia, hyperinsulinemia, and excess corticosterone on hypoglycemic counterregulation. Am J Physiol 281 (2001) E455-E465
21. Davis S.N., Shavers C., Costa F., and Mosqueda-Garcia R. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 98 (1996) 680-691
22. Davis S.N., Shavers C., Davis B., and Costa F. Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. J Clin Invest 100 (1997) 429-438
23. Panksepp J., Pollack A., Krost K., Meeker R.B., and Ritter M. Feeding in response to repeated protamine zinc insulin injections. Physiol Behav 14 (1974) 487-493
24. Lotter E.C., and Woods S.C. Injections of insulin and changes in body weight. Physiol Behav 18 (1976) 293-297
25. Kanarek R.B., Kaufman-Marks R., and Lipeles B.J. Increased carbohydrate intake as a function of insulin administration in rats. Physiol Behav 25 (1980) 779-782
26. Mitrakou A., Ryan C., Veneman T., Mokan M., Jenssen T., Kiss I., et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 260 (1991) E67-E74
27. Tkacs N.C., Dunn-Meynell A.A., and Levin B.E. Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia. Diabetes 49 (2000) 820-826
28. Heller S.R., and Cryer P.E. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40 (1991) 223-226
29. Ovalle F., Fanelli C.G., Paramore D.S., Hershey T., Craft S., and Cryer P.E. Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes 47 (1998) 1472-1479
30. Cryer P.E. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness. Endocr Metab Clin North Am 28 (1999) 495-500
31. Towler D.A., Havlin C.E., Craft S., and Cryer P.E. Mechanism of awareness of hypoglycemia. Diabetes 42 (1993) 1791-1798
32. Ritter S., Bugarith K., and Dinh T.T. Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J Comp Neurol 432 (2001) 197-216
33. Sawchenko P.E., and Swanson L.W. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res 257 (1987) 275-325
34. Tucker D.C., Saper C.B., Ruggiero D.A., and Reis D.J. Organization of central adrenergic pathways: I. Relationships of ventrolateral medullary projections to the hypothalamus and spinal cord. J Comp Neurol 259 (1987) 591-603
35. Byrum C.E., and Guyenet P.G. Afferent and efferent connections of the A5 noradrenergic cell group in the rat. J Comp Neurol 261 (1987) 529-542
36. He B., White B.D., Edwards G.L., and Martin R.J. Neuropeptide Y antibody attenuates 2-deoxy-d-glucose induced feeding in rats. Brain Res 781 (1998) 348-350
37. Akabayashi A., Wahlestedt C., Alexander J.T., and Leibowitz S.F. Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Mol Brain Res 21 (1994) 55-61
38. Minami S., Kamegai J., Sugihara H., Suzuki N., Higuchi H., and Wakabayashi I. Central glucoprivation evoked by administration of 2-deoxy-d-glucose induces expression of the c-fos gene in a subpopulation of neuropeptide Y neurons in the rat hypothalamus. Mol Brain Res 33 (1995) 305-310
39. Sergeyev V., Broberger C., Gorbatyuk O., and Hokfelt T. Effect of 2-mercaptoacetate and 2-deoxy-d-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus. Neurol Rep 11 (2000) 117-121
40. Giraudo S.Q., Kim E.M., Grace M.K., Billington C.J., and Levine A.S. Effect of peripheral 2-DG on opioid and neuropeptide Y gene expression. Brain Res 792 (1998) 136-140
41. Akabayashi A., Zaia C.T., Silva I., Chae H.J., and Leibowitz S.F. Neuropeptide Y in the arcuate nucleus is modulated by alterations in glucose utilization. Brain Res 621 (1993) 343-348
42. Sindelar D.K., Ste Marie L., Miura G., Palmiter R.D., McMinn J.E., Morton G.J., et al. Neuropeptide Y is required for hyperphagic feeding in response to neuroglucopenia. Endocrinology 145 (2004) 3363-3368
43. Balagura S. Conditioned glycemic response in the control of food intake. J Comp Physiol Psychol 65 (1968) 30-32
44. Balagura S., and Harrell L.E. Neuroendocrine conditioning: conditioned feeding after alterations in glucose utilization. Am J Physiol 228 (1975) 392-396
45. The Diabetes Control and Complications Trial Research Group. Weight gain associated with intensive therapy in the diabetes control and complications trial. Diabetes Care 11 (1988) 567-573
46. Purnell J.Q., Hokanson J.E., Marcovina S.M., Steffes M.W., Clearly P.A., and Brunzell J.D. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. JAMA 280 (1998) 140-146
47. Ritter R.C., Roelke M., and Neville M. Glucoprivic feeding behavior in absence of other signs of glucoprivation. Am J Physiol 234 (1978) E617-E621
48. Ritter S., Bellin S.I., and Pelzer N.L. The role of gustatory and postingestive signals in the termination of delayed glucoprivic feeding and hypothalamic norepinephrine turnover. J Neurosci 12 (1981) 1354-1360
49. Friedman M.I., and Granneman J. Food intake and peripheral factors after recovery from insulin-induced hypoglycemia. Am J Physiol 13 (1983) R374-R382
50. Heller S. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 65S (2004) S23-S27
51. Purnell J.Q., Dev R.K., Steffes M.W., Clearly P.A., Palmer J.P., Hirsch I.B., et al. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the diabetes control and complications trial. Diabetes 52 (2003) 2623-2629
52. Jones R.G., and Booth D.A. Low dose-response for 2-deoxy-d-glucose-induced feeding, and the involvement of peripheral factors. Physiol Behav 15 (1975) 85-90
53. Friedman M.I., and Granneman J. Feeding after recovery from 2-deoxyglucose injection: cerebral and peripheral factors. Am J Physiol 244 (1983) R383-R388